Letter

Dada Publishes 2022 ESG Report

Retrieved on: 
Wednesday, May 31, 2023
Nexus, Communication, Letter, Employment, Female, All-China Federation of Industry and Commerce, Merchant, Data collection, Woman, Corporate social responsibility, Privacy, Carbon, CSR, NPS, Business ethics, A (Cyrillic), Ethics, JDDJ, Growth, ESG, Health, Safety, Commerce, Audit, Management, Health insurance, Life insurance, Online shopping, Renewable energy

SHANGHAI, China, May 31, 2023 (GLOBE NEWSWIRE) -- Dada Nexus Limited (“Dada” or the “Company”) (NASDAQ: DADA), China’s leading local on-demand delivery and retail platform, today released its 2022 ESG report.

Key Points: 
  • SHANGHAI, China, May 31, 2023 (GLOBE NEWSWIRE) -- Dada Nexus Limited (“Dada” or the “Company”) (NASDAQ: DADA), China’s leading local on-demand delivery and retail platform, today released its 2022 ESG report.
  • In 2022, Dada remained steadfast in its commitment to delivering a sustainable future.
  • The report details Dada’s key initiatives and development in ESG efforts surrounding shareholders, employees, users, partners, and community.
  • To view the report in full, please visit the ESG section on the Company’s IR website at https://ir.imdada.cn/corporate/environmental-social-and-governance .

Management Discussion and Analysis – Outlook 2023

Retrieved on: 
Wednesday, May 31, 2023
Panic, Lighting, Maintenance, Letter, Partnership, Wi-Fi, AT, Bank statement, The Home Depot, Internet of things, Disclosure, Water, OTC Markets Group, POS, Retail, Target, Outlook, HVAC, Fast-food restaurant, McDonald's, Platform, MD, Managed services, Growth, 7-Eleven, Service delivery platform, Rare-earth element, Mobile phone, Consumer electronics, Video game, U.S. Bancorp

NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- This management’s discussion and analysis (MD&A) includes information that will help you understand management’s perspective on the Outlook for 2023 for Balincan USA Inc (BCNN) and its subsidiary Tekumo LLC (the “Company”).

Key Points: 
  • NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- This management’s discussion and analysis (MD&A) includes information that will help you understand management’s perspective on the Outlook for 2023 for Balincan USA Inc (BCNN) and its subsidiary Tekumo LLC (the “Company”).
  • Please see the disclosure relative to forward-looking statements at the base of this discussion.
  • The Company offers a service delivery platform that solves the "last-mile" of installing, monitoring, and maintaining technology systems and smart connected devices.
  • These projects will be sold on a monthly recurring revenue basis
    Our gross margin of 40% from 2022/21 is expected to continue in 2023.

Harvard Pilgrim Health Care Data Breach Investigation

Retrieved on: 
Wednesday, May 31, 2023
Harvard Pilgrim Health Care, PLLC, Medicare, Name, Social, Letter, Family, Social Security, Pharmaceutical industry

NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- TheGrantLawFirm, PLLC announces that it is investigating claims against Harvard Pilgrim Health Care (“Harvard Pilgrim”).

Key Points: 
  • NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- TheGrantLawFirm, PLLC announces that it is investigating claims against Harvard Pilgrim Health Care (“Harvard Pilgrim”).
  • Harvard Pilgrim recently announced that on April 17, 2023, it discovered a cybersecurity ransomware attack that impacted about 2 million users of the Harvard Pilgrim Health Care Commercial and Medicare Advantage Stride plans.
  • It disclosed that its investigation revealed that copies of private health care information was taken from the system during the period of March 29, 2023, to April 17, 2023.
  • If you received a data breach letter, call Lynda J.

Freshpet Responds to JANA Partners’ Letter Regarding Freshpet Board Actions

Retrieved on: 
Tuesday, May 30, 2023
Benchmark, Classification, Public Interest Declassification Board, Policy, JANA, Retirement, Annual general meeting, Letter, Charter, Financial adviser

We write on behalf of our client, Freshpet, Inc. (the “Company”), in response to your letter of May 25, 2023 on behalf of JANA Strategic Investments Benchmark Master Fund, L.P. (“JANA”).

Key Points: 
  • We write on behalf of our client, Freshpet, Inc. (the “Company”), in response to your letter of May 25, 2023 on behalf of JANA Strategic Investments Benchmark Master Fund, L.P. (“JANA”).
  • Your letter contains several erroneous and unfounded claims about the Company’s board of directors (the “Board”), the composition of the Board’s classes, and the date of the Company’s 2023 Annual Meeting of Stockholders.
  • Furthermore, you have omitted information critical to understanding the intent and effect of the Board’s actions addressed by your letter.
  • In fact, Mr. Norris is not standing for re-election pursuant to the retirement policy adopted by the Board in June 2021.

FCM Pledges to Lock Up its MindMed Shares Until June 2025 to Demonstrate its Alignment with Fellow Shareholders and Confidence in its Plan to Restore MindMed

Retrieved on: 
Tuesday, May 30, 2023
BLUE, FOR, Commit, HAND2, Research, CMO, History, Risk, SEDAR, Letter, Mouth, MindMed, FCM, Security (finance), Management, Tobacco, Pharmaceutical industry

SHERIDAN, Wyo., May 30, 2023 (GLOBE NEWSWIRE) -- FCM MM Holdings, LLC ("FCM"), beneficially owning approximately 3.5% of the outstanding common shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (“MindMed” or the “Company”), today announces it sent a letter to shareholders from Dr. Scott Freeman. The letter calls out MindMed’s incumbent Board’s and management’s efforts to distract shareholders rather than confront their history of poor performance and destruction of shareholder value. In addition, Dr. Freeman pledges to lock-up his MindMed shares in conjunction with FCM, Mr. Jake Freeman and FCM’s director candidates until June 15, 2025, if FCM’s slate of director candidates is elected.

Key Points: 
  • MindMed has serious problems including:
    a history of punitive and dilutive financings,
    ill-conceived and chronically delayed clinical trials.
  • We have a plan to realign costs to support research and development and start a Phase III clinical trial in 2023.
  • Vote FOR the FCM director candidates who have confidence in their plan to drive shareholder value and are putting you first.
  • Shareholders who have questions or require any assistance with their vote, please contact Okapi Partners LLC, at (855) 305-0856 or [email protected]

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

Retrieved on: 
Tuesday, May 30, 2023
Workforce, Letter, International, File, Bank statement, Calendar, Form 10-K, Notification, Form 10-Q, IBB, Form, IAM, Security (finance), Cryptocurrency, WALL

The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.

Key Points: 
  • The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.
  • The Notification Letter stated that the Company remains delinquent in filing its Form 10-K for the period ended December 31, 2022 (the “Form 10-K”) and has until June 20, 2023 to submit a plan to regain compliance with respect to these delinquent reports.
  • If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the filing due date of the 10-K, or until October 16, 2023, to regain compliance.
  • The Company intends to file the Form 10-Q and the Form 10-K with the SEC as soon as practicable and regain compliance with Nasdaq’s continued listing requirements.

Nano Dimension’s Conference Call: Special Tender Offer to Increase Ownership in Stratasys

Retrieved on: 
Tuesday, May 30, 2023
WHEN, Internet, Bank statement, AND, Schedule, Stratasys, Letter, TIME, Cryptocurrency

Waltham, Mass, May 30, 2023 (GLOBE NEWSWIRE) -- As previously announced, Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “NANO” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, will host a conference call on Tuesday, May 30th, 2023 at 9:00 a.m. EDT (4:00 p.m. IDT) to discuss its special tender offer to increase its ownership in Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys”), as well as the merits of Stratasys’ proposed deal with Desktop Metal, Inc. (NYSE: DM) (“Desktop Metal”, “DM”), which are being positioned as an alternative to the Company’s aforementioned special tender offer.

Key Points: 
  • On May 25, 2023, Nano Dimension filed with the SEC a tender offer statement on Schedule TO, including an offer to purchase, a related letter of transmittal and other tender offer documents.
  • The Company expects that Stratasys will file with the SEC a solicitation/recommendation statement on Schedule 14D-9, as required by the tender offer rules.
  • Investors and security holders may obtain a free copy of the offer to purchase, the related letter of transmittal, certain other tender offer documents and the solicitation/recommendation statement (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to Georgeson LLC, the information agent for the tender offer, named in the tender offer statement.
  • Copies of the documents filed with the SEC by Stratasys may be obtained at no charge on the investor relations page of Stratasys’ website at www.stratasys.com .

Spexis provides business update and announces financial results for the full year 2022

Retrieved on: 
Tuesday, May 30, 2023
Partnership, Inhalation, QIDP, Clinical trial, LR, Pharmacokinetics, Research, Bronchiectasis, COPA, BLX, USD, Transplant, Pseudomonas aeruginosa, Plasma, Kidney, Bone marrow, Patient, Collection, Lower respiratory tract infection, Cystic fibrosis, Adolescence, MPV, Mortality, Growth, R, Urinary tract infection, FDA, Letter, CHF, SGI, CF, Safety, Pharmaceutical industry, Spexy Beast

ALLSCHWIL, Switzerland, May 29, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced its financial results for the full year of 2022 and provided a strategic business update.

Key Points: 
  • Spexis has worldwide rights to ColiFin® ex-Europe and is focused on developing the product first for the U.S. market.
  • Spexis announced positive results from the Phase 1 clinical trial of balixafortide (BLX) in patients with renal impairment in September 2022.
  • In January 2023, Spexis reported promising safety and pharmacokinetics results from a first-in-human study with inhaled murepavadin (iMPV), a novel macrocycle compound.
  • Spexis’ cash position as of December 31, 2022 was CHF 1.8 million (cash and cash equivalents).

UMeWorld Limited to Purchase Three Palm Oil Mills Totaling Two Million Metric tons of Capacity for $90 Million of Convertible Preferred Equity at $4 Per Share

Retrieved on: 
Tuesday, May 30, 2023
Diglyceride, Letter, FFB Stadium, Palm oil, Plant, OTC, Growth, ESG, PINK, Convertible, Global environmental analysis, CPO

MIAMI, May 30, 2023 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC:PINK UMEWF) has signed a binding Letter of Intent to purchase three Palm oil mills totaling 240 TPH (Tons per Hour) - 300 TPH production capacity in three separate locations in Malaysia. This represents nearly 2 million metric tons of Fresh Fruit Bunches (FFBs) production capacity with roughly net through put of 600 thousand metric tons per year or approximately 3.3 million barrels of Crude Palm Oil (CPO) per year of licensed capacity. As of the end of April, the price of Malaysian palm oil was about $1,000/ton. Current market value of this capacity is $600 million of revenue per year or about $5.40 per outstanding share.

Key Points: 
  • MIAMI, May 30, 2023 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC:PINK UMEWF) has signed a binding Letter of Intent to purchase three Palm oil mills totaling 240 TPH (Tons per Hour) - 300 TPH production capacity in three separate locations in Malaysia.
  • This represents nearly 2 million metric tons of Fresh Fruit Bunches (FFBs) production capacity with roughly net through put of 600 thousand metric tons per year or approximately 3.3 million barrels of Crude Palm Oil (CPO) per year of licensed capacity.
  • The Company will issue Convertible Preferred Equity of $90 million, which is convertible at a floor of $4 per share.
  • Having the premier ESG refining technology will position us to benefit from Malaysia’s huge investment commitment to sustainable palm oil capacity growth.

Marathon Digital Holdings: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Sunday, May 28, 2023
Marathon Digital, Webcast, Form 10-K, Letter, Corporate finance, Marathon, Comment, Bank statement, Cryptocurrency

LOS ANGELES, May 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Marathon Digital Holdings, Inc. (“Marathon” or the “Company”) (NASDAQ: MARA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Marathon investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • LOS ANGELES, May 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Marathon Digital Holdings, Inc. (“Marathon” or the “Company”) (NASDAQ: MARA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors.
  • Marathon investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.